323 related articles for article (PubMed ID: 6767977)
1. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
[TBL] [Abstract][Full Text] [Related]
3. The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development.
Reiter EO; Root AW; Duckett GE
J Clin Endocrinol Metab; 1976 Aug; 43(2):400-11. PubMed ID: 780368
[TBL] [Abstract][Full Text] [Related]
4. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
[TBL] [Abstract][Full Text] [Related]
5. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
Shimon I; Lubina A; Gorfine M; Ilany J
J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
[TBL] [Abstract][Full Text] [Related]
6. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
7. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
[TBL] [Abstract][Full Text] [Related]
8. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.
Gross KM; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin and testosterone measurements after estrogen administration to adult men, prepubertal and pubertal boys, and men with hypogonadotropism: evidence for maturation of positive feedback in the male.
Kulin HE; Reiter EO
Pediatr Res; 1976 Jan; 10(1):46-51. PubMed ID: 1107952
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
11. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
Bagatell CJ; Dahl KD; Bremner WJ
J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
[TBL] [Abstract][Full Text] [Related]
12. Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.
Yen SS; Rebar R; Vandenberg G; Ehara Y; Siler T
J Reprod Fertil Suppl; 1973 Dec; 20(0):137-61. PubMed ID: 4599401
[TBL] [Abstract][Full Text] [Related]
13. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
14. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
[TBL] [Abstract][Full Text] [Related]
15. [Effect of treatment of idiopathic hypogonadotropic hypogonadism with an LHRH infusion pump].
Goicolea Opacua I; Cortázar Galarza A; Cacho García L; Guimón Bardesi M; Vázquez García JA
Rev Clin Esp; 1989; 185(3):128-30. PubMed ID: 2516346
[TBL] [Abstract][Full Text] [Related]
16. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
[TBL] [Abstract][Full Text] [Related]
18. Responses to constant infusion of LH-RH in girls with primary hypogonadism.
Reiter EO; Duckett GE; Root AW
Obstet Gynecol; 1980 Sep; 56(3):339-43. PubMed ID: 6448363
[TBL] [Abstract][Full Text] [Related]
19. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
[TBL] [Abstract][Full Text] [Related]
20. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
Wang CF; Lasley BL; Yen SS
J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
